BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34961547)

  • 41. Efficacy of duloxetine in patients with knee osteoarthritis or chronic low back pain with early pain reduction: An exploratory post-hoc analysis of Japanese phase 3, 1-year extension studies.
    Itoh N; Uchio Y; Tsuji T; Ishida M; Ochiai T; Konno S
    J Orthop Sci; 2022 May; 27(3):717-724. PubMed ID: 33958268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
    Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
    BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perioperative duloxetine administration reduces pain after high tibial osteotomy and non-steroidal anti-inflammatory administration: A prospective, controlled study.
    Otsuki S; Okamoto Y; Ikeda K; Wakama H; Okayoshi T; Neo M
    Knee; 2022 Oct; 38():42-49. PubMed ID: 35908360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the effects of duloxetine and pregabalin on pain and associated factors in patients with knee osteoarthritis.
    Illeez OG; Oktay KNK; Aktas I; Ozkan FU; Nazligül T; Begoglu FA; Kaysin MY; Atici A; Akpinar P
    Rev Assoc Med Bras (1992); 2022 Mar; 68(3):377-383. PubMed ID: 35442367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.
    Myers J; Wielage RC; Han B; Price K; Gahn J; Paget MA; Happich M
    BMC Musculoskelet Disord; 2014 Mar; 15():76. PubMed ID: 24618328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Individualization of Migraine Prevention: A Randomized Controlled Trial of Psychophysical-based Prediction of Duloxetine Efficacy.
    Kisler LB; Weissman-Fogel I; Coghill RC; Sprecher E; Yarnitsky D; Granovsky Y
    Clin J Pain; 2019 Sep; 35(9):753-765. PubMed ID: 31241488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inferring distinct mechanisms in the absence of subjective differences: Placebo and centrally acting analgesic underlie unique brain adaptations.
    Tétreault P; Baliki MN; Baria AT; Bauer WR; Schnitzer TJ; Apkarian AV
    Hum Brain Mapp; 2018 May; 39(5):2210-2223. PubMed ID: 29417694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement.
    Graven-Nielsen T; Wodehouse T; Langford RM; Arendt-Nielsen L; Kidd BL
    Arthritis Rheum; 2012 Sep; 64(9):2907-16. PubMed ID: 22421811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee.
    Brown JP; Boulay LJ
    Ther Adv Musculoskelet Dis; 2013 Dec; 5(6):291-304. PubMed ID: 24294303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duloxetine for treating painful neuropathy or chronic pain.
    Lunn MP; Hughes RA; Wiffen PJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of duloxetine efficacy in addition to self-management in painful temporomandibular disorders: A randomised, placebo-controlled clinical trial.
    Ferreira DMAO; Soares FFC; Raimundini AA; Bonjardim LR; Costa YM; Conti PCR
    J Oral Rehabil; 2024 Mar; 51(3):476-486. PubMed ID: 37994185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: effect on human mechanistic pain biomarkers and clinical pain.
    Arendt-Nielsen L; Jiang GL; DeGryse R; Turkel CC
    Scand J Rheumatol; 2017 Jul; 46(4):303-316. PubMed ID: 27733091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial.
    Vranken JH; Hollmann MW; van der Vegt MH; Kruis MR; Heesen M; Vos K; Pijl AJ; Dijkgraaf MGW
    Pain; 2011 Feb; 152(2):267-273. PubMed ID: 21078545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuromuscular exercise and pain neuroscience education compared with pain neuroscience education alone in patients with chronic pain after primary total knee arthroplasty: study protocol for the NEPNEP randomized controlled trial.
    Larsen JB; Skou ST; Arendt-Nielsen L; Simonsen O; Madeleine P
    Trials; 2020 Feb; 21(1):218. PubMed ID: 32197629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analgesic effect of perioperative duloxetine in patients after total knee arthroplasty: a prospective, randomized, double-blind, placebo-controlled trial.
    Yuan M; Tang T; Ding Z; Li H; Zhou Z
    BMC Musculoskelet Disord; 2022 Mar; 23(1):242. PubMed ID: 35279155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exercise therapy and patient education versus intra-articular saline injections in the treatment of knee osteoarthritis: an evidence-based protocol for an open-label randomised controlled trial (the DISCO trial).
    Bandak E; Overgaard AF; Kristensen LE; Ellegaard K; Guldberg-Møller J; Bartholdy C; Hunter DJ; Altman RD; Christensen R; Bliddal H; Henriksen M
    Trials; 2021 Jan; 22(1):18. PubMed ID: 33407791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Relationship Between Clinical and Quantitative Measures of Pain Sensitization in Knee Osteoarthritis.
    Moore RL; Clifford AM; Moloney N; Doody C; Smart KM; O'Leary H
    Clin J Pain; 2020 May; 36(5):336-343. PubMed ID: 31977373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial.
    Rovati LC; Brambilla N; Blicharski T; Connell J; Vitalini C; Bonazzi A; Giacovelli G; Girolami F; D'Amato M
    Osteoarthritis Cartilage; 2020 Jan; 28(1):22-30. PubMed ID: 31526875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
    Majdinasab N; Kaveyani H; Azizi M
    Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.